Items without sitelinks
From determinar.ia.br - Determine suas informações
Showing below up to 50 results in range #5,701 to #5,750.
- Harmful effects of insulin or oral hypoglycaemic drugs (Q107114)
- Harmful effects of ophthalmological drugs or preparations (Q107113)
- Harmful effects of otorhinolaryngological drugs or preparations (Q107112)
- Harmful effects of antithyroid drugs (Q107111)
- Harmful effects of fluoride preparations (Q107110)
- Harmful effects of keratolytics, keratoplastics, or other hair treatment drugs or preparations (Q107109)
- Harmful effects of Podophyllin (Q107108)
- Harmful effects of silver nitrate (Q107107)
- Harmful effects of Methyl salicylate (Q107106)
- Harmful effects of emollients, demulcents or protectants (Q107105)
- Harmful effects of other dental drugs, topically applied (Q107104)
- Harmful effects of thyroid hormones or substitutes (Q107103)
- Harmful effects of antipruritics (Q107102)
- Harmful effects of acidifying or alkalising agents (Q107101)
- Harmful effects of topical corticosteroid preparations (Q107100)
- Harmful effects of other local antifungal, anti-infective or anti-inflammatory drugs (Q107099)
- Harmful effects of other primarily systemic agents, not elsewhere classified (Q107098)
- Harmful effects of other local astringents or local detergents (Q107097)
- Harmful effects of plasma substitutes (Q107096)
- Harmful effects of Iodine, antiseptic (Q107095)
- Harmful effects of thrombolytic drug (Q107094)
- Harmful effects of natural blood or blood products (Q107093)
- Harmful effects of anticoagulant antagonists, vitamin K or other coagulants (Q107092)
- Harmful effects of other fibrinolysis-affecting drugs (Q107091)
- Harmful effects of other antineoplastic drugs (Q107090)
- Harmful effects of iron or its compounds (Q107089)
- Harmful effects of immunosuppressive agents (Q107088)
- Harmful effects of enzymes (Q107087)
- Harmful effects of Vitamin B12, folic acid or other anti-megaloblastic-anaemia preparations (Q107086)
- Harmful effects of antithrombotic drugs (Q107085)
- Harmful effects of other laxatives (Q107084)
- Harmful effects of anticoagulants (Q107083)
- Harmful effects of Diphenhydramine (Q107082)
- Harmful effects of antineoplastic antimetabolites (Q107081)
- Harmful effects of antineoplastic natural products (Q107080)
- Harmful effects of or exposure to emetics (Q107079)
- Harmful effects of antidiarrhoeal drugs (Q107078)
- Harmful effects of other H1-receptor antagonists (Q107077)
- Harmful effects of antiallergic or antiemetic drugs (Q107076)
- Harmful effects of digestants (Q107075)
- Harmful effects of substances, Drugs, medicaments or biological substances, Drugs primarily affecting the autonomic nervous system, Predominantly beta-adrenoreceptor agonists (Q107074)
- Harmful effects of substances, Drugs, medicaments or biological substances, Drugs primarily affecting the autonomic nervous system, Centrally-acting or adrenergic-neuron-blocking agents (Q107073)
- Harmful effects of other antacids or anti-gastric-secretion drugs (Q107072)
- Harmful effects of stimulant laxatives (Q107071)
- Harmful effects of saline or osmotic laxatives (Q107070)
- Harmful effects of substances, Drugs, medicaments or biological substances, Drugs primarily affecting the autonomic nervous system, Predominantly alpha-adrenoreceptor agonists (Q107069)
- Harmful effects of substances, Drugs, medicaments or biological substances, Drugs primarily affecting the autonomic nervous system, Alpha-adrenoreceptor antagonists (Q107068)
- Harmful effects of substances, Drugs, medicaments or biological substances, Drugs primarily affecting the autonomic nervous system, Ganglionic blocking drugs (Q107067)
- Harmful effects of Histamine H2-receptor blockers (Q107066)
- Harmful effects of substances, Drugs, medicaments or biological substances, Drugs primarily affecting the autonomic nervous system, Beta-adrenoreceptor antagonists (Q107065)
